KEBILIDI
NDC 52856-601, eladocagene exuparvovec-tneq, suspension, from PTC Therapeutics, Inc..
- Product NDC
- 52856-601
- Status
- Listed
- Labeler
- PTC Therapeutics, Inc.
- Dosage form
- SUSPENSION
- Route
- INTRACEREBRAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125722
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/52856-601 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ELADOCAGENE EXUPARVOVEC560000000000 {GC}/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 52856-601-01 | 52856060101 | 1 VIAL, GLASS in 1 CARTON (52856-601-01) / .5 mL in 1 VIAL, GLASS (52856-601-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9d6a6401-c6b5-4f29-af11-67707d249482
Use it
Look up 52856-601 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/52856-601 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 52856-601. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.